AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options ...
TIME names NanoKnife one of 2025’s Best Inventions — already treating prostate cancer in Toronto with precise, function-preserving results. TIME's recognition of NanoKnife (IRE) reinforces what we’ve ...
The NanoKnife system employs non-thermal IRE ablation to destroy tumour cells while preserving surrounding anatomy.
Zacks Investment Research on MSN
ANGO expands NanoKnife in Europe for multi-organ tumor ablation
AngioDynamics ANGO recently announced expanded indications in Europe for its NanoKnife System, broadening its clinical utility in soft tissue tumor ablation. The expanded approval covers NanoKnife’s ...
Function-Preserving Therapy Recognized in the Medical Devices Category for its Use of Irreversible Electroporation (IRE) Technology in Treatment of Prostate Tumors For the past 25 years, TIME’s Best ...
Peer-reviewed findings demonstrate high disease control and quality-of-life preservation, supporting shift toward focal therapy in prostate treatment “The publication of the PRESERVE study in European ...
PSA testing and digital rectal exams are crucial for early detection of prostate cancer, enabling timely intervention and improved outcomes. Treatment options include active surveillance, surgery, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results